A5 Noradrenergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The A5 noradrenergic cell group is a cluster of catecholaminergic neurons located in the pontine tegmentum that synthesizes and releases norepinephrine. As part of the lateral pontine tegmental field, the A5 region plays critical roles in respiratory control, autonomic regulation, pain modulation, and cardiovascular function. These neurons are increasingly recognized as important players in neurodegenerative diseases that affect brainstem systems, particularly those involving autonomic dysfunction and respiratory failure. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000459 | noradrenergic cell |
| Database | ID | Name | Confidence | [2]
|----------|----|------|------------| [3]
| Cell Ontology | CL:0000459 | noradrenergic cell | Medium | [4]
The A5 region is situated in the ventrolateral pontine tegmentum, just ventral to the locus coeruleus and medial to the superior olivary complex. Key anatomical features include: [5]
The A5 region contains: [6]
The A5 region receives extensive inputs from:
A5 neurons project to:
Spinal cord:
Brainstem:
Forebrain:
A5 neurons are characterized by:
A5 neurons exhibit:
A5 neurons express various receptor subtypes:
In Parkinson's disease, A5 dysfunction contributes to:
Post-mortem studies show reduced tyrosine hydroxylase in A5 region in PD patients.
MSA shows particularly severe A5 involvement:
The A5 region is among the earliest sites of pathological changes in MSA.
A5 involvement in ALS manifests as:
A5 function can be assessed through:
Modulating A5 function for treatment:
Alpha-2 agonists: Clonidine for respiratory control
Norepinephrine reuptake inhibitors: For autonomic function
Respiratory stimulants: Targeting A5 pathways
Deep brain stimulation: Pontine targets
Cell-Types/A7-Noradrenergic-Neurons — Adjacent noradrenergic group
Cell-Types/Locus-Coeruleus-Neurons — Major noradrenergic nucleus
Cell-Types/A1-Noradrenergic-Neurons — Medullary noradrenergic group
Brain-Regions/Pons — Location of A5 region
Mechanisms/Respiratory-Dysfunction — Breathing control in neurodegeneration
The study of A5 Noradrenergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Guyenet PG et al. A5 neurons and sympathetic nerve activity. Auton Neurosci. 2020. 2020. ↩︎
Berciano J et al. A5 region involvement in Parkinson's disease. Mov Disord. 2018. 2018. ↩︎
Simonneau G et al. Respiratory dysfunction in ALS. J Neurol Sci. 2019. 2019. ↩︎
Satel X et al. Autonomic failure in neurodegenerative disease. Clin Auton Res. 2020. 2020. ↩︎
Pierrefiche O et al. A5 neuron activity in sleep apnea. Sleep Med Rev. 2021. 2021. ↩︎
Saper CB et al. Pontine tegmental noradrenergic system. J Comp Neurol. 2017. 2017. ↩︎